EDGAR Filing Documents for 0001193125-17-265654

Form 8-K - Current report:

SEC Accession No. 0001193125-17-265654

Filing Date

2017-08-23

Accepted

2017-08-23 16:16:04

Documents

Period of Report

2017-08-17

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d641007d8k.htm	8-K	39697
2	EX-4.1	d641007dex41.htm	EX-4.1	657009
3	EX-99.1	d641007dex991.htm	EX-99.1	8272
4	EX-99.2	d641007dex992.htm	EX-99.2	10624
5	GRAPHIC	g641007001.jpg	GRAPHIC	3596
6	GRAPHIC	g641007002.jpg	GRAPHIC	4154
	Complete submission text file	0001193125-17-265654.txt		728036

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4

Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800

Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)